AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33707626 — intervention group
Group type: EXPERIMENTAL
Intervention: Common SNPs with the most captured prediction accuracy in the selected sets
Number of subjects: 14827
Study 33707626 — intervention group
Group type: EXPERIMENTAL
Intervention: Small number of SNPs obtained from GWAS results
Number of subjects: 14827
Study 32311006 — intervention group
Group type: EXPERIMENTAL
Intervention: Men who used alcohol before suicide (12.6%)
Number of subjects: 242
Study 32311006 — intervention group
Group type: EXPERIMENTAL
Intervention: Married status, mental disorder, depressive symptoms, hopelessness, impulsivity, loneliness, social support, family function, quality of life
Number of subjects: 242
Study 32311006 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic physical illness and functions of daily living
Number of subjects: 242
Study 32311006 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms and hopelessness
Number of subjects: 242
Study 36415961 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term methimazole (LT-MMI)
Number of subjects: 130
Study 36415961 — intervention group
Group type: COMPARATOR
Intervention: Radioactive iodine (RAI)
Number of subjects: 130
Study 33938135 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF)
Number of subjects: 120
Study 33938135 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean-low carbohydrate diet (MED/LC)
Number of subjects: 120
Study 33938135 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (PA+)
Number of subjects: 120
Study 33938135 — intervention group
Group type: COMPARATOR
Intervention: Physical activity (PA−)
Number of subjects: 120
Study 35844456 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfortable nursing mode based on optimized MIoT
Number of subjects: 70
Study 35844456 — intervention group
Group type: COMPARATOR
Intervention: Comfortable nursing mode
Number of subjects: 70
Study 33902317 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi awareness and therapeutic option consideration
Number of subjects: 15
Study 33902317 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation frequency of Tai Chi
Number of subjects: 15
Study 33902317 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting recommendation of Tai Chi
Number of subjects: 15
Study 33902317 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestions for increasing Tai Chi uptake
Number of subjects: 15
Study 33492374 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus an automated series of 9 educational or reminder text messages in the week prior to scheduled colonoscopy
Number of subjects: 753
Study 33492374 — intervention group
Group type: COMPARATOR
Intervention: Usual care (written instructions and nurse telephone call)
Number of subjects: 753
Study 33492374 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus an automated series of 9 educational or reminder text messages
Number of subjects: 753
Study 32968274 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a high-status car (intervention)
Number of subjects: 0
Study 32968274 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition (control)
Number of subjects: 0
Study 32097392 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) treatment offered in 96% of cases
Number of subjects: 114
Study 33852730 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention (TMI) in addition to group counseling, nicotine patches, and written material; Duration: 6 weeks
Number of subjects: 77
Study 33852730 — intervention group
Group type: COMPARATOR
Intervention: Standard care (group counseling, nicotine patches, and written material)
Number of subjects: 77
Study 33130494 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional curettage with cement filled plus fixator
Number of subjects: 14
Study 33130494 — intervention group
Group type: COMPARATOR
Intervention: Distal femur resection with tumorous prosthesis replaced
Number of subjects: 14
Study 33731649 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mile run
Number of subjects: 30
Study 33731649 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-mile run
Number of subjects: 30
Study 33731649 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall runs (2-mile and 4-mile)
Number of subjects: 30
Study 34903344 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES) used in 76% of BVS-ISR patients
Number of subjects: 117
Study 34903344 — intervention group
Group type: EXPERIMENTAL
Intervention: BVS-ISR
Number of subjects: 117
Study 34903344 — intervention group
Group type: COMPARATOR
Intervention: DES in BVS-ISR
Number of subjects: 117
Study 32522268 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 Modic Changes (n = 118)
Number of subjects: 180
Study 32522268 — intervention group
Group type: COMPARATOR
Intervention: Type 2 Modic Changes (n = 62)
Number of subjects: 180
Study 32522268 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Springing test
Number of subjects: 180
Study 35574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Early circumcision (within 24 hours of delivery)
Number of subjects: 148
Study 35574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate circumcision (between 24 to 72 hours of age)
Number of subjects: 148
Study 35574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Late circumcision (between 1 and 3 weeks of age)
Number of subjects: 148
Study 34675311 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming for 15 minutes
Number of subjects: 297
Study 34675311 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming for 30 minutes
Number of subjects: 297
Study 34675311 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming for 45 minutes
Number of subjects: 297
Study 34675311 — intervention group
Group type: COMPARATOR
Intervention: No prewarming (Control group)
Number of subjects: 297
Study 34098214 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein group (HPG) - 25% daily calorie of protein
Number of subjects: 70
Study 34098214 — intervention group
Group type: COMPARATOR
Intervention: Regular-protein group (RPG) - 15% daily calorie of protein
Number of subjects: 70
Study 32325320 — intervention group
Group type: EXPERIMENTAL
Intervention: Early transplanting and applying irrigation
Number of subjects: 109
Study 32325320 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmers' perceptions of salinity
Number of subjects: 109
Study 32325320 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmers' awareness of salinity
Number of subjects: 109
Study 32325320 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmers' interpretation of salinity levels
Number of subjects: 109
Study 34117153 — intervention group
Group type: EXPERIMENTAL
Intervention: Early drain removal (EDR)
Number of subjects: 312
Study 34117153 — intervention group
Group type: COMPARATOR
Intervention: Routine drain removal (RDR)
Number of subjects: 312
Study 33323802 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 3819
Study 33323802 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 3819
Study 34134881 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release injectable naltrexone before release (BR)
Number of subjects: 146
Study 34134881 — intervention group
Group type: COMPARATOR
Intervention: Referral to treatment after release (AR)
Number of subjects: 146
Study 32345253 — intervention group
Group type: COMPARATOR
Intervention: SMAQ (Simplified Medication Adherence Questionnaire) at T1 (baseline)
Number of subjects: 926
Study 32345253 — intervention group
Group type: COMPARATOR
Intervention: SMAQ (Simplified Medication Adherence Questionnaire) at T2 (follow-up)
Number of subjects: 926
Study 32345253 — intervention group
Group type: COMPARATOR
Intervention: SMAQ items 1 to 6
Number of subjects: 926
Study 32345253 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement invariance of SMAQ
Number of subjects: 926
Study 35184889 — intervention group
Group type: EXPERIMENTAL
Intervention: CROSS strategy
Number of subjects: 100
Study 35184889 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 100
Study 35184889 — intervention group
Group type: COMPARATOR
Intervention: Perioperative chemotherapy
Number of subjects: 100
Study 33550268 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention plus usual care
Number of subjects: 303
Study 33550268 — intervention group
Group type: COMPARATOR
Intervention: Usual eczema care alone
Number of subjects: 303
Study 32147082 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment plus conventional treatment
Number of subjects: 134
Study 32147082 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 134
Study 33957854 — intervention group
Group type: EXPERIMENTAL
Intervention: Influvac® Tetra (subunit, inactivated influenza vaccine)
Number of subjects: 480
Study 33957854 — intervention group
Group type: COMPARATOR
Intervention: VaxiFlu‐4 (split virion, inactivated influenza vaccine)
Number of subjects: 480
Study 33169944 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% carbamide peroxide (CP) for 30 min/day
Number of subjects: 80
Study 33169944 — intervention group
Group type: COMPARATOR
Intervention: 10% carbamide peroxide (CP) for 4 h/day
Number of subjects: 80
Study 33310500 — intervention group
Group type: COMPARATOR
Intervention: Bilateral ECT (BT)
Number of subjects: 91
Study 33310500 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Unilateral ECT (RUL)
Number of subjects: 91
Study 35973226 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel antimicrobial wound gel system
Number of subjects: 1500
Study 35973226 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 1500
Study 33958432 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial mediastinal cryobiopsy
Number of subjects: 197
Study 33958432 — intervention group
Group type: COMPARATOR
Intervention: Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA)
Number of subjects: 197
Study 33958432 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial mediastinal cryobiopsy and EBUS‐TBNA
Number of subjects: 197
Study 32306029 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic correlation analysis using cross‐trait linkage disequilibrium (LD) score regression
Number of subjects: 0
Study 32306029 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0
Study 32306029 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent genome‐wide association study (GWAS) replication
Number of subjects: 0
Study 35779194 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 0
Study 35779194 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-CTEAE
Number of subjects: 0
Study 33951477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute intermittent hypoxia (AIH); 15, 1-min episodes (hypoxia: 10.3% O2) interspersed with room air breathing (1.5 min, 21% oxygen)
Number of subjects: 17
Study 33951477 — intervention group
Group type: COMPARATOR
Intervention: Sham (21% O2)
Number of subjects: 17
Study 33951477 — intervention group
Group type: EXPERIMENTAL
Intervention: AIH
Number of subjects: 17
Study 33277921 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage III/IV periodontitis
Number of subjects: 404
Study 33277921 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade C periodontitis
Number of subjects: 404
Study 33277921 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression of periodontitis
Number of subjects: 404
Study 33277921 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage progression
Number of subjects: 404
Study 35353636 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using gallium aluminum arsenide (GaAlAs) laser with parameters: wavelength of 810 nm, power of 0.5% ± 20% W, energy density of 4 J/cm2.
Number of subjects: 25
Study 35353636 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (control group).
Number of subjects: 25
Study 33351989 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% chlorhexidine gluconate solution preoperatively
Number of subjects: 322
Study 32756878 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Condition (reading negative, discriminatory tweets)
Number of subjects: 57
Study 32756878 — intervention group
Group type: COMPARATOR
Intervention: Neutral Condition (reading neutral tweets)
Number of subjects: 57
Study 35316820 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA)
Number of subjects: 70
Study 35316820 — intervention group
Group type: COMPARATOR
Intervention: Leukocyte-Poor Platelet-Rich Plasma (LP-PRP)
Number of subjects: 70
Study 32589290 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting for 3 hours
Number of subjects: 20
Study 35942796 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-Free Vaginal Tape (TVT)
Number of subjects: 223
Study 35942796 — intervention group
Group type: COMPARATOR
Intervention: Polyacrylamide Hydrogel (PAHG)
Number of subjects: 223
Study 33143774 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA-rich meal
Number of subjects: 0
Study 33143774 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA-rich meal
Number of subjects: 0
Study 33143774 — intervention group
Group type: EXPERIMENTAL
Intervention: PUFA-rich meal
Number of subjects: 0
Study 33143774 — intervention group
Group type: COMPARATOR
Intervention: All meals
Number of subjects: 0
Study 32564466 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic total mesorectal excision (LTME) + transanal ISR
Number of subjects: 26
Study 32564466 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic low anterior resection (Control)
Number of subjects: 26
Study 36112791 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual training intervention group (n=52)
Number of subjects: 110
Study 36112791 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=58)
Number of subjects: 110
Study 35737699 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-based cavity preparation with acid etching (test group I, n = 21)
Number of subjects: 75
Study 35737699 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-based cavity preparation without acid etching (test group II, n = 21)
Number of subjects: 75
Study 35737699 — intervention group
Group type: COMPARATOR
Intervention: Conventional diamond burs preparation (control group, n = 33)
Number of subjects: 75
Study 33453391 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib (300 mg/day or 200 mg/day based on body weight and platelet count)
Number of subjects: 265
Study 33453391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 33453391 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 265
Study 32078170 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)
Number of subjects: 20
Study 32078170 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (TI or supraglottic high-frequency JV)
Number of subjects: 20
Study 32078170 — intervention group
Group type: EXPERIMENTAL
Intervention: THRIVE
Number of subjects: 20
Study 32078170 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 20
Study 35467580 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) group
Number of subjects: 21
Study 35467580 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Simulation (PS) group
Number of subjects: 21
Study 35467580 — intervention group
Group type: COMPARATOR
Intervention: Reading/Video control group
Number of subjects: 21
Study 33610422 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg resveratrol daily for 3 months
Number of subjects: 78
Study 33610422 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg placebo daily for 3 months
Number of subjects: 78
Study 34402090 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise group (n=54)
Number of subjects: 81
Study 34402090 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (n=27)
Number of subjects: 81
Study 36045021 — intervention group
Group type: EXPERIMENTAL
Intervention: CD20-targeting agents
Number of subjects: 2428
Study 36045021 — intervention group
Group type: COMPARATOR
Intervention: No CD20-targeting agents
Number of subjects: 2428
Study 36045021 — intervention group
Group type: COMPARATOR
Intervention: B-symptoms
Number of subjects: 2428
Study 36045021 — intervention group
Group type: COMPARATOR
Intervention: Elevated LDH
Number of subjects: 2428
Study 36045021 — intervention group
Group type: COMPARATOR
Intervention: Low hemoglobin
Number of subjects: 2428
Study 34815288 — intervention group
Group type: EXPERIMENTAL
Intervention: Human breast milk-based fortifier
Number of subjects: 222
Study 34815288 — intervention group
Group type: COMPARATOR
Intervention: Bovine protein-based fortifier
Number of subjects: 222
Study 35258443 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem 2 g every 8 hours (TID)
Number of subjects: 60
Study 35258443 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem 2 g TID plus rifampin at 20 mg/kg once daily
Number of subjects: 60
Study 35258443 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem 1 g TID
Number of subjects: 60
Study 35258443 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem 3 g once daily
Number of subjects: 60
Study 36011833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive−physical dual‐task training (n = 29)
Number of subjects: 58
Study 36011833 — intervention group
Group type: COMPARATOR
Intervention: Functional balance training (n = 29)
Number of subjects: 58
Study 32143655 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU diary
Number of subjects: 126
Study 32143655 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 126
Study 32860696 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency chest wall oscillation and conventional chest physical therapy (breathing exercises, early ambulation, and cough training) thrice per week for 8 weeks
Number of subjects: 60
Study 32860696 — intervention group
Group type: COMPARATOR
Intervention: Traditional chest physical therapy (breathing exercises, early ambulation, and cough training) thrice per week for 8 weeks
Number of subjects: 60
Study 32056459 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized double-blind controlled trials (RDB)
Number of subjects: 24
Study 32056459 — intervention group
Group type: COMPARATOR
Intervention: Non-randomized double-blind trials
Number of subjects: 24
Study 34237210 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with temozolomide followed by 6 cycles of adjuvant temozolomide (arm A)
Number of subjects: 90
Study 34237210 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone (arm B)
Number of subjects: 90
Study 34162789 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 0
Study 34162789 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 0
Study 34162789 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 0
Study 34162789 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi
Number of subjects: 0
Study 34162789 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐4
Number of subjects: 16
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐21
Number of subjects: 16
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐1, SKA‐4, SKA‐6, SKA‐17
Number of subjects: 16
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐11, SKA‐17
Number of subjects: 16
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐19
Number of subjects: 16
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐6, SKA‐21, SKA‐27, AWS‐1
Number of subjects: 16
Study 33622986 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA‐17
Number of subjects: 16
Study 34784592 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency yoga breathing
Number of subjects: 38
Study 34784592 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate nostril yoga breathing
Number of subjects: 38
Study 34784592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bellows yoga breathing
Number of subjects: 38
Study 34784592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumblebee yoga breathing
Number of subjects: 38
Study 33689919 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed sample size method for matched-pair cluster randomization design with continuous outcomes
Number of subjects: 0
Study 33689919 — intervention group
Group type: EXPERIMENTAL
Intervention: Bias-corrected variance estimators
Number of subjects: 0
Study 35246214 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-sparing therapies
Number of subjects: 42
Study 35246214 — intervention group
Group type: COMPARATOR
Intervention: Opioid-based therapies
Number of subjects: 42
Study 32068667 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration desipramine titrated to reach a serum concentration level of 15 to 65 ng/mL
Number of subjects: 142
Study 32068667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and active placebo medication (benztropine mesylate, 0.125 mg)
Number of subjects: 142
Study 32068667 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration desipramine and CBT
Number of subjects: 142
Study 32068667 — intervention group
Group type: COMPARATOR
Intervention: Active benztropine placebo medication
Number of subjects: 142
Study 33734127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac sodium (1.5 mg/kg)
Number of subjects: 110
Study 33734127 — intervention group
Group type: COMPARATOR
Intervention: Intravenous paracetamol (15 mg/kg)
Number of subjects: 110
Study 33047618 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of hemoglobin levels using cyanmethaemoglobin method
Number of subjects: 32
Study 33047618 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic and health status factors
Number of subjects: 32
Study 32212810 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/m2 cisplatin weekly (Arm A)
Number of subjects: 60
Study 32212810 — intervention group
Group type: COMPARATOR
Intervention: 100 mg/m2 cisplatin once every 3 weeks (Arm B)
Number of subjects: 60